Is Pentoxifylline Able to Improve Olfactory Sensitivity?
NCT00660868 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2016-02-05
Summary
Signal processing in the olfactory neuron could be influenced by inhibition of enzymes like phosphodiesterase. Pentoxifylline is a unspecific phosphodiesterase inhibitor. The hypothesis is that pentoxifylline could lead to increased sensitivity to odors.
Conditions
- Olfaction Disorders
Interventions
- DRUG
-
Pentoxifylline retard 400mg
Agapurin retard 400mg 3/day per os for 3 weeks
Sponsors & Collaborators
-
Technische Universität Dresden
lead OTHER
Principal Investigators
-
Volker Gudziol, Dr. med. · Technische Universität Dresden
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- Germany
Study Locations
More Related Trials
-
Lipoic Acid as a Treatment for Acute Optic Neuritis
NCT01294176 ·Status: COMPLETED ·Phase: PHASE1
-
Droxidopa / Pyridostigmine in Orthostatic Hypotension
NCT01370512 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms
NCT00389831 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica
NCT05978063 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Growth Hormone in Amyotrophic Lateral Sclerosis
NCT00635960 ·Status: COMPLETED ·Phase: PHASE2
-
Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy (Vestibular Neuronitis)
NCT05024448 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
NCT06633003 ·Status: RECRUITING ·Phase: NA
-
Single-Dose Pharmacokinetics (PK) Study of Novel Neurogenic Compound NSI-189
NCT01310881 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study With Repeated Doses of Stalevo
NCT00693862 ·Status: COMPLETED ·Phase: PHASE1
-
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
NCT01083667 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
NCT00049803 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety, Tolerability, and Efficacy of UthPeak NMNH (Reduced Nicotinamide Mononucleotide) in Healthy Adult Participants
NCT06889740 ·Status: COMPLETED ·Phase: NA
-
Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity
NCT00689208 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
NCT02720744 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)
NCT00152958 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
NCT01067222 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
NCT00345800 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
NCT00051961 ·Status: COMPLETED
-
Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease
NCT06912048 ·Status: RECRUITING ·Phase: NA
-
A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study
NCT06631300 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of the Efficacy of Vertistop® D and Vertistop® L in the Prevention of BPPV Recurrence
NCT05748249 ·Status: COMPLETED ·Phase: PHASE1
-
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation
NCT07084311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of Tolfenamic Acid in Individuals With PSP at 12-Weeks
NCT04253132 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prednisone Treatment for Vestibular Neuronitis
NCT00271791 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Roflumilast in Prevention of Peripheral Neuropathy
NCT05884281 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2